Obrocea Mihail 4
4 · MAIA Biotechnology, Inc. · Filed Aug 2, 2022
Insider Transaction Report
Form 4
Obrocea Mihail
Chief Medical Officer
Transactions
- Purchase
Common Stock
2022-08-01$5.00/sh+1,000$5,000→ 27,100 total
Footnotes (1)
- [F1]These shares were purchased by the reporting person in the issuer's initial public offering, which closed on August 1, 2022.